{
    "2018-05-02": [
        [
            {
                "time": "2018-04-25",
                "original_text": "Novo Nordisk (NVO) Beats Q1 Earnings Estimates, Sales Miss",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Q1",
                        "Earnings",
                        "Beats",
                        "Sales Miss"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-26",
                "original_text": "NVS and NVO: Which Has Higher Upside Potential?",
                "features": {
                    "keywords": [
                        "NVS",
                        "NVO",
                        "Upside Potential"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-27",
                "original_text": "These Pharma Stocks Offer the Most Upside Potential",
                "features": {
                    "keywords": [
                        "Pharma Stocks",
                        "Upside Potential"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-28",
                "original_text": "European Markets Climbed On Positive Corporate Earnings",
                "features": {
                    "keywords": [
                        "European Markets",
                        "Climbed",
                        "Positive Corporate Earnings"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-29",
                "original_text": "Drugmaker Novo Nordisk beats first quarter profit expectations, nudges up 2018 outlook",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Profit Expectations",
                        "Outlook",
                        "First Quarter"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-30",
                "original_text": "We have a policy of not taking list price increases of ab...",
                "features": {
                    "keywords": [
                        "Policy",
                        "Price Increases"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-01",
                "original_text": "[$$] Novo Nordisk shares climb as it lifts sales and profit",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Shares Climb",
                        "Sales",
                        "Profit"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "Novo Nordisk Q1 Profit Up 6%; Lifts Low End Of FY18 Outlook Range - Quick Facts",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Q1 Profit",
                        "FY18 Outlook"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}